Updates in the Management of Mantle Cell Lymphoma

Updates in the Management of Mantle Cell Lymphoma

Episodes

Specialty:

All

Year:

All

EP. 1: Updates in Management of Mantle Cell Lymphoma

January 29th 2020

EP. 2: Selecting a BTK Inhibitor for Mantle Cell Lymphoma

January 29th 2020

EP. 3: BTK Inhibitors in MCL: AEs, Specificity, and Interactions

January 29th 2020

EP. 4: Mantle Cell Lymphoma: Chemotherapy-Free Treatment Options

January 29th 2020

EP. 5: CAR T-Cell Therapy and the Future Management of MCL

January 29th 2020

EP. 6: MCL: FDA Approval of a Second-Generation BTK Inhibitor

January 29th 2020

EP. 7: Priority Review in RET Fusion+ NSCLC and Thyroid Cancers, Breakthrough Status in MDS, and More

January 29th 2020

Trending on OncLive

FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer

Treatment Tailoring and Weighing Alternative Formulations Support Optimal TKI Deployment in CML

Casdatifan Demonstrates Activity in Advanced Clear Cell RCC

HER2+ Maintenance Therapy Approvals and Innovative Brain Metastasis Care Reshape Breast Cancer Management

Lisaftoclax Plus Acalabrutinib Received Breakthrough Therapy Designation in China for Treatment-Naive CLL/SLL